Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gopinathan

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Advances in Neurology|January 1, 1990
Mesulergine: a dopamine agonist with novel properties in Parkinson's diseaseA N Lieberman, G Gopinathan, P Pasternack, et al.
Neurology|May 1, 1987
Advanced Parkinson's disease: use of partial dopamine agonist, ciladopaA Lieberman, G Gopinathan, A Neophytides, et al.
JAMA|November 28, 1977
Treatment of Parkinson's disease with lergotrile mesylateA Lieberman, E Estey, M Kupersmith, et al.
New York State Journal of Medicine|December 1, 1987
Deprenyl versus placebo in Parkinson disease: a double-blind studyA N Lieberman, G Gopinathan, A Neophytides, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptineA N Lieberman, G Gopinathan, H Hassouri, et al.
Advances in Neurology|January 1, 1984
Pergolide and lisuride in advanced Parkinson's diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Advances in Neurology|January 1, 1983
The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's diseaseM Leibowitz, A N Lieberman, A Neophytides, et al.
Neurology|September 1, 1978
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson diseaseA Lieberman, E Estey, G Gopinathan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1984
Disposition of oral lisuride in Parkinson's diseaseR S Burns, G Gopinathan, M Hümpel, et al.
European Neurology|January 1, 1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's diseaseA Lieberman, G Gopinathan, E Miller, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Advances in Neurology|January 1, 1990
Mesulergine: a dopamine agonist with novel properties in Parkinson's diseaseA N Lieberman, G Gopinathan, P Pasternack, et al.
Neurology|May 1, 1987
Advanced Parkinson's disease: use of partial dopamine agonist, ciladopaA Lieberman, G Gopinathan, A Neophytides, et al.
JAMA|November 28, 1977
Treatment of Parkinson's disease with lergotrile mesylateA Lieberman, E Estey, M Kupersmith, et al.
New York State Journal of Medicine|December 1, 1987
Deprenyl versus placebo in Parkinson disease: a double-blind studyA N Lieberman, G Gopinathan, A Neophytides, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptineA N Lieberman, G Gopinathan, H Hassouri, et al.
Advances in Neurology|January 1, 1984
Pergolide and lisuride in advanced Parkinson's diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Advances in Neurology|January 1, 1983
The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's diseaseM Leibowitz, A N Lieberman, A Neophytides, et al.
Neurology|September 1, 1978
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson diseaseA Lieberman, E Estey, G Gopinathan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1984
Disposition of oral lisuride in Parkinson's diseaseR S Burns, G Gopinathan, M Hümpel, et al.
European Neurology|January 1, 1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's diseaseA Lieberman, G Gopinathan, E Miller, et al.
Pageof 5